Jonathan Sapir

Orbital apex syndrome (OAS) is characterized by optic neuropathy and ophthalmoplegia and is generally associated with poor visual prognosis. The aim of this study was to describe patients with acute OAS who demonstrated substantial recovery of visual function and ocular motility. We retrospectively reviewed the medical records of patients treated for OAS at a tertiary medical center between 2019 and 2024 whose condition ultimately proved reversible. Data on demographics, clinical findings, imaging, management, and follow-up were collected. Six patients (three female, three male; age range 14–87 years) were included and followed for a median follow-up of 7 months (range 2–31). All presented with reduced vision and ophthalmoplegia of varying severity. Underlying etiologies included inflammatory disease (n = 2), lymphoma, infection, blunt trauma, and post-surgical OAS of undetermined etiology (n = 1 each). Treatment was directed at the underlying cause. Visual acuity ranged from 20/30 to hand motion (HM) at presentation and 20/15 to 20/60 at the final visit. Improvement in vision and ocular motility occurred after a median time to clinical improvement of 2.37 months (range 0.25–5 months). Near-complete recovery of ocular motility was observed in all patients, with only one retaining mild abduction limitation. These findings highlight a subset of OAS cases with favorable outcomes and emphasize the importance of early diagnosis and etiology-directed management.